PamBio

OverviewSuggest Edit

PamBio operates as a biotechnology company that develops drug therapy for acute bleeding conditions. The product is an anti-fibrinolytic agent is an inactive, mutated Tissue Plasminogen Activator (tPA).

TypePrivate
Founded2014
HQNazareth, IL
Websitengt3vc.com

Recent NewsAll News

  • OTTEK
    PamBio Blog

Latest Updates

Cybersecurity ratingAMore

Key People/Management at PamBio

Amir Toren

Amir Toren

CTO & Business Development Director
Zohar Gendler

Zohar Gendler

Managing Partner & CEO
Nizar Mishael

Nizar Mishael

Managing Partner & CFO
Show more

PamBio Office Locations

PamBio has an office in Nazareth
Nazareth, IL (HQ)
13 Wadi el-Haj St
Show all (1)

PamBio Financials and Metrics

Summary Metrics

Founding Date

2014

PamBio total Funding

$7 m

PamBio latest funding size

$7 m

Time since last funding

4 years ago
PamBio's latest funding round in July 2016 was reported to be $7 m. In total, PamBio has raised $7 m
Show all financial metrics

PamBio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

PamBio Online and Social Media Presence

Embed Graph

PamBio Blogs

OTTEK

OTTek has developed the FIOT (Flow In Over Tube), a versatile, on-demand, easy-to-assemble, cost-effective, colonoscopy assist device. The post OTTEK appeared first on New Generation Technology (NGT)3.
Show more

PamBio Frequently Asked Questions

  • When was PamBio founded?

    PamBio was founded in 2014.

  • Who are PamBio key executives?

    PamBio's key executives are Amir Toren, Zohar Gendler and Nizar Mishael.

  • Who are PamBio competitors?

    Competitors of PamBio include Metacrine, Fulcrum Therapeutics and Yumanity Therapeutics.

  • Where is PamBio headquarters?

    PamBio headquarters is located at 13 Wadi el-Haj St, Nazareth.

  • Where are PamBio offices?

    PamBio has an office in Nazareth.

  • How many offices does PamBio have?

    PamBio has 1 office.